Status:
COMPLETED
Non-pharmaceutical Motion Sickness Mitigation
Lead Sponsor:
Mayo Clinic
Conditions:
Healthy
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular ...
Eligibility Criteria
Inclusion
- Must be able to consent to participate themselves.
- Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
- No racial ethnic groups will be excluded.
- Must be fluent speakers of English.
Exclusion
- History of vestibular disease, migraine, or significant balance disorder.
- Traumatic brain injury.
- Recent middle ear infection or recent motion sickness (within 72 hours).
- History of severe motion sensitivity.
- Women who are pregnant.
Key Trial Info
Start Date :
March 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04859868
Start Date
March 12 2021
End Date
August 30 2022
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259